Clinical Research Directory
Browse clinical research sites, groups, and studies.
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Sponsor: AstraZeneca
Summary
The purpose of this study is to measure the efficacy and safety of torvutatug samrotecan (torvu-sam) with or without bevacizumab compared to standard of care (SoC) as maintenance treatment in participants with platinum-sensitive relapsed ovarian cancer (PSR OC)
Official title: A Randomised, Open-label, Phase III Study of Torvutatug Samrotecan With or Without Bevacizumab Versus Standard of Care as Second- or Third-Line Maintenance Treatment in Participants With Platinum-sensitive Relapsed Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (TREVI-OC-03)
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2026-09-29
Completion Date
2031-10-27
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
Torvutatug samrotecan
FRa targeting antibody drug conjugate Topoisomerase I inhibitor
Bevacizumab
Monoclonal antibody inhibitor of Vascular Endothelial Growth Factor
Locations (79)
Research Site
Anchorage, Alaska, United States
Research Site
Columbia, Maryland, United States
Research Site
Detroit, Michigan, United States
Research Site
Albany, New York, United States
Research Site
Bay Shore, New York, United States
Research Site
Greenlawn, New York, United States
Research Site
New Hyde Park, New York, United States
Research Site
New York, New York, United States
Research Site
Rego Park, New York, United States
Research Site
Cleveland, Ohio, United States
Research Site
Cleveland, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Mayfield Heights, Ohio, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Willow Grove, Pennsylvania, United States
Research Site
Morgantown, West Virginia, United States
Research Site
Auchenflower, Australia
Research Site
Blacktown, Australia
Research Site
Clayton, Australia
Research Site
Liverpool, Australia
Research Site
Porto Alegre, Brazil
Research Site
São Caetano do Sul, Brazil
Research Site
São José do Rio Preto, Brazil
Research Site
São José dos Campos, Brazil
Research Site
São Paulo, Brazil
Research Site
Teresina, Brazil
Research Site
Vitória, Brazil
Research Site
Abbotsford British Columbia, British Columbia, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Beijing, China
Research Site
Guangdong Province, China
Research Site
Guangzhou, China
Research Site
Wuhan, China
Research Site
Bad Homburg, Germany
Research Site
Bonn, Germany
Research Site
Brandenburg, Germany
Research Site
Gütersloh, Germany
Research Site
Homburg, Germany
Research Site
Kassel, Germany
Research Site
Mainz, Germany
Research Site
Mannheim, Germany
Research Site
Wiesbaden, Germany
Research Site
Ahmedabad, India
Research Site
Bangalore, India
Research Site
Gurgaon, India
Research Site
Kottayam, India
Research Site
Madurai, India
Research Site
Nashik, India
Research Site
Nashik, India
Research Site
New Delhi, India
Research Site
Vadodara, India
Research Site
Fukuoka, Japan
Research Site
Fukushima, Japan
Research Site
Kobe, Japan
Research Site
Kōtoku, Japan
Research Site
Kyoto, Japan
Research Site
Minatoku, Japan
Research Site
Natori-shi, Japan
Research Site
Sagamihara-shi, Japan
Research Site
Shinjuku-ku, Japan
Research Site
Suita-shi, Japan
Research Site
Toyoake-shi, Japan
Research Site
Yokohama, Japan
Research Site
Goyang-si, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Kaohsiung City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Taichung, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan
Research Site
Bangkok, Thailand
Research Site
Bangkok, Thailand
Research Site
Bangkok, Thailand
Research Site
Hat Yai, Thailand
Research Site
Muang, Thailand